Patent ID: 8193239

Claim:
A compound of formula (I) wherein y represents 0, 1 or 2; m and n are independently 0, 1, 2 or 3 (such that the sum of m and n is equal to 1, 2 or 3); R 1 is C 1-3 alkyl optionally substituted with one or more substituents selected from halogen, hydroxy or C 1-3 alkoxy; R 2 is selected from hydrogen, halogen, CN, CF 3 , C 1-3 alkyl or C 1-3 alkoxy; Q represents phenyl that is optionally substituted by 1 to 3 substituents independently selected from halogen, carboxyl, hydroxyl, oxo, nitro, cyano, mercapto, C 1-6 alkyl group (itself optionally substituted by hydroxyl, C 1-6 alkoxy, NR 65 R 66 , phenyl or morpholinyl), C 3-6 cycloalkyl, C 2-6 alkenyl, trifluoromethyl, C 1-6 alkoxy (optionally substituted by halogen), C 1-6 alkylcarbonyl, C 1-6 alkylcarbonyloxy, C 1-6 alkoxycarbonyl, —NR 53 R 54 , —C(O)NR 55 R 56 , NR 57 C(O)R 58 , SO 2 NR 59 R 60 , NR 61 SO 2 R 62 , S(O) v R 63 , OS(O 2 )R 64 , benzyloxy and C 1-6 alkylpiperazinyl; R 53 and R 54 each independently represent hydrogen, C 1-6 alkyl or C 3-6 cycloalkyl, or R 53 and R 54 together with the nitrogen atom to which they are attached form a 4- to 7-membered saturated heterocyclic ring; v is 0, 1 or 2; R 55 and R 56 each independently represent hydrogen, C 1-6 alkyl or C 3-6 cycloalkyl, or R 55 and R 56 together with the nitrogen atom to which they are attached form a 4- to 7-membered saturated heterocyclic ring; R 59 and R 60 each independently represent hydrogen, C 1-6 alkyl or C 3-6 cycloalkyl, or R 59 and R 60 together with the nitrogen atom to which they are attached form a 4- to 7-membered saturated heterocyclic ring; each R 57 , R 58 , R 61 , R 62 R 63 and R 64 independently represents a hydrogen atom or a C 1-6 alkyl or C 3-6 cycloalkyl group; R 65 and R 66 each independently represent hydrogen, C 1-6 alkyl or C 3-6 cycloalkyl, or R 65 and R 66 together with the nitrogen atom to which they are attached form a 4- to 7-membered saturated heterocyclic ring; or a pharmaceutically-acceptable salt thereof.